Cardiovascular disease in Latin American patients with systemic lupus erythematosus: A cross-sectional study and a systematic review

Autoimmune Diseases

Volumn 2013, Issue , 2013, Pages

  Amaya Amaya, Jenny ^a   Sarmiento Monroy, Juan Camilo ^a   Caro Moreno, Julián ^a   Molano González, Nicolás ^a   Mantilla, Rubén D ^a   Rojas Villarraga, Adriana ^a   Anaya, Juan Manuel ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOTOXIC AGENT; HAIR DYE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LA ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PESTICIDE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RITUXIMAB; RO ANTIBODY; SM ANTIBODY; STEROID; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; TRIACYLGLYCEROL;

AGE; ALOPECIA; ANEMIA; ARTHROPATHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COFFEE; COMORBIDITY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DEPRESSION; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE DURATION; DYSLIPIDEMIA; EDUCATION; EPILEPSY; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FIBROMYALGIA; GENDER; GLOMERULONEPHRITIS; HAND EDEMA; HEADACHE; HEPATITIS A; HEREDITY; HISPANIC; HOUSEWIFE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; LEUKOPENIA; LIVEDO RETICULARIS; LUNG EMBOLISM; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPENIA; MALARIA; NEPHRITIS; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OCCUPATION; ONSET AGE; OSTEOPOROSIS; PEPTIC ULCER; PERICARDITIS; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PSYCHOSIS; PULMONARY HYPERTENSION; PYURIA; SEDENTARY LIFESTYLE; SMOKING; SOCIAL STATUS; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASCULITIS; VENEREAL DISEASE REACTION TEST;

EID: 84888876526     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2013/794383     Document Type: Article

References (159)

1. Liu Z., Davidson A., Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nature Medicine 2012 18 871 882 10.1038/nm.2752
2. Tsokos G. C., Mechanisms of disease: systemic lupus erythematosus. The New England Journal of Medicine 2011 365 22 2110 2121 2-s2.0-82555196095
3. Guerra S. G., Vyse T. J., Graham D. S. C., The genetics of lupus: a functional perspective. Arthritis Research and Therapy 2012 14 article 211 10.1186/ar3844
4. D'Cruz D. P., Khamashta M. A., Hughes G. R., Systemic lupus erythematosus. The Lancet 2007 369 9561 587 596 2-s2.0-33846897631 10.1016/S0140-6736(07)60279-7 (Pubitemid 46241445)
5. Urowitz M. B., Bookman A. A. M., Koehler B. E., Gordon D. A., Smythe H. A., Ogryzlo M. A., The bimodal mortality pattern of systemic lupus erythematosus. The American Journal of Medicine 1976 60 2 221 225 2-s2.0-0017295808
6. Björnådal L., Yin L., Granath F., Klareskog L., Ekbom A., Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. Journal of Rheumatology 2004 31 4 713 719 2-s2.0-1842530440 (Pubitemid 38451257)
7. Bitton A., Gaziano T., The Framingham heart study's impact on global risk assessment. Progress in Cardiovascular Diseases 2010 53 1 68 78 2-s2.0-77954153205 10.1016/j.pcad.2010.04.001
8. Schoenfeld S. R., Kasturi S., Costenbader K. H., The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Seminars in Arthritis and Rheumatism 2013 43 1 77 95 10.1016/j.semarthrit.2012.12.002
9. Esdaile J. M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du Berger R., Côte R., Grover S. A., Fortin P. R., Clarke A. E., Senécal J. L., Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and Rheumatism 2001 44 10 2331 2337 (Pubitemid 32977500)
10. González Burchard E., Borrell L. N., Choudhry S., Naqvi M., Tsai H. J., Rodriguez-Santana J. R., Chapela R., Rogers S. D., Mei R., Rodriguez-Cintron W., Arena J. F., Kittles R., Perez-Stable E. J., Ziv E., Risch N., Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. The American Journal of Public Health 2005 95 12 2161 2168 2-s2.0-28444459900 10.2105/AJPH.2005.068668 (Pubitemid 41740246)
11. Price A. L., Patterson N., Yu F., Cox D. R., Waliszewska A., McDonald G. J., Tandon A., Schirmer C., Neubauer J., Bedoya G., Duque C., Villegas A., Bortolini M. C., Salzano F. M., Gallo C., Mazzotti G., Tello-Ruiz M., Riba L., Aguilar-Salinas C. A., Canizales-Quinteros S., Menjivar M., Klitz W., Henderson B., Haiman C. A., Winkler C., Tusie-Luna T., Ruiz-Linares A., Reich D., A genomewide admixture map for latino populations. The American Journal of Human Genetics 2007 80 6 1024 1036 2-s2.0-34250894969 10.1086/518313 (Pubitemid 47579340)
12. Lora E., Health perceptions in Latin America. Health Policy and Planning 2012 27 555 569
13. Barreto S. M., Miranda J. J., Figueroa J. P., Schmidt M. I., Munoz S., Kuri-morales P. P., Silva J. B. Jr., Epidemiology in Latin America and the Caribbean: current situation and challenges. International Journal of Epidemiology 2012 41 2 557 571 2-s2.0-84859647779 10.1093/ije/dys017
14. Pons-Estel B. A., Catoggio L. J., Cardiel M. H., Soriano E. R., Gentiletti S., Villa A. R., Abadi I., Caeiro F., Alvarellos A., Alarcón-Segovia D., The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among 'hispanics'. Medicine 2004 83 1 1 17 2-s2.0-9144226796 10.1097/01.md.0000104742.42401.e2 (Pubitemid 38124852)
15. Chaiamnuay S., Bertoli A. M., Fernández M., Apte M., Vilá L. M., Reveille J. D., Alarcón G. S., The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. Journal of Clinical Rheumatology 2007 13 3 128 133 2-s2.0-35148889828 10.1097/RHU.0b013e31815ac6f4 (Pubitemid 47549177)
16. Pons-Estel G. J., González L. A., Zhang J., Burgos P. I., Reveille J. D., Vilá L. M., Alarcón G. S., Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology 2009 48 7 817 822 2-s2.0-67650096909 10.1093/rheumatology/kep102
17. Toloza S. M. A., Uribe A. G., McGwin G. Jr., Alarcón G. S., Fessler B. J., Bastian H. M., Vilá L. M., Wu R., Shoenfeld Y., Roseman J. M., Reveille J. D., Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events. Arthritis and Rheumatism 2004 50 12 3947 3957 2-s2.0-10444248119 10.1002/art.20622 (Pubitemid 39643943)
18. Ho K. T., Ahn C. W., Alarcón G. S., Baethge B. A., Tan F. K., Roseman J., Bastian H. M., Fessler B. J., McGwin G. Jr., Vilá L. M., Calvo-Alén J., Reveille J. D., Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology 2005 44 10 1303 1307 2-s2.0-27144483360 10.1093/rheumatology/kei014 (Pubitemid 41487966)
19. Burgos P. I., McGwin G. Jr., Reveille J. D., Vilá L. M., Alarcón G. S., Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology 2010 49 9 1720 1725 2-s2.0-77955836323 10.1093/rheumatology/keq140 keq140
20. Smith E. L., Shmerling R. H., The American college of rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999 8 8 586 595 2-s2.0-0032758601 10.1191/096120399680411317 (Pubitemid 29520523)
21. Hochberg M. C., Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997 40 9 1725 2-s2.0-0031229830
22. Colombia, Law no. 30, Public Service in Higher Education, 1992
23. Colombia, Law no. 115, General on education, 1994
24. Barragán-Martínez C., Speck-Hernández C. A., Montoya-Ortiz G., Mantilla R. D., Anaya J. M., Rojas-Villarraga A., Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS ONE 2012 7 12 e51506 10.1371/journal.pone.0051506
25. Shoenfeld Y., Cervera R., Diagnostic Criteria in Autoimmune Diseases 2008
26. Rojas-Villarraga A., Amaya-Amaya J., Rodriguez-Rodriguez A., Mantilla R. D., Anaya J. M., Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Diseases 2012 2012 9 254319 10.1155/2012/254319
27. Anaya J. M., Corena R., Castiblanco J., Rojas-Villarraga A., Shoenfeld Y., The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Review of Clinical Immunology 2007 3 4 623 635 2-s2.0-34547104853 10.1586/1744666X.3.4.623 (Pubitemid 47096486)
28. Anaya J. M., The autoimmune tautology. Arthritis Research and Therapy 2010 12 6, article 147 2-s2.0-78049521843
29. Cárdenas-Roldán J., Rojas-Villarraga A., Anaya J. M., How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Medicine 2013 11 article 73 10.1186/1741-7015-11-73
30. Jones D. W., Hall J. E., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension 2004 43 1 1 3 2-s2.0-0347418917 10.1161/01.HYP.0000110061.06674.ca (Pubitemid 38031902)
31. Stone N. J., Bilek S., Rosenbaum S., Recent national cholesterol education program adult treatment panel III update: adjustments and options. The American Journal of Cardiology 2005 96 4 53E 59E 2-s2.0-23744444361 10.1016/j.amjcard.2005.06.006 (Pubitemid 41140371)
32. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 18 1837 1847 2-s2.0-0032510639 (Pubitemid 28213628)
33. Grundy S. M., Pasternak R., Greenland P., Smith S. Jr., Fuster V., Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American heart association and the American college of cardiology. Circulation 1999 100 13 1481 1492 2-s2.0-0033613228 (Pubitemid 29451714)
34. Asia Pacific Cohort Studies Collaboration, The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease. International Journal of Epidemiology 2006 35 4 1025 1033 2-s2.0-33749647724 10.1093/ije/dyl058 (Pubitemid 44540758)
35. American Diabetes Association, Standards of medical care in diabetes-2012. Diabetes Care 2012 35 supplement 1 S11 S63
36. Reiner Z., Catapano A. L., de Backer G., Graham I., Taskinen M. R., Wiklund O., Agewall S., Alegria E., Chapman M. J., Durrington P., Erdine S., Halcox J., Hobbs R., Kjekshus J., Filardi P. P., Riccardi G., Storey R. F., Wood D., ESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). European Heart Journal 2011 32 14 1769 1818 10.1093/eurheartj/ehr158
37. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association, Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. The British Medical Journal 2000 320 7236 705 708 2-s2.0-0034635810
38. Liberati A., Altman D. G., Tetzlaff J., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009 62 e1 34
39. Mateen F. J., Oh J., Tergas A. I., Bhayani N. H., Kamdar B. B., Titles versus titles and abstracts for initial screening of articles for systematic reviews. Clinical Epidemiology 2013 6 89 95 10.2147/CLEP.S43118
40. OCEBM Levels of Evidence Working Group, The Oxford 2011 Levels of Evidence 2011 Oxford Centre for Evidence-Based Medicine
41. Onetti L., Villafañe S., Menso E., Drenkard C., Gamron S., Barberis G., Onetti C. M., Hyperhomocystinemia as a thrombotic risk factor in patients suffering from systemic lupus erithematosus and antiphospholipid syndrome. Revista de la Facultad de Ciencias Médicas 2005 62 3 19 23 2-s2.0-39049196134
42. Signorelli F. V., Salles G. F., Papi J. A., Antiphospholipid syndrome as predictor of mortality in Brazilian patients with systemic lupus erythematosus. Lupus 2011 20 article 419
43. Cabiedes J., Cabral A. R., Alarcon-Segovia D., Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate move strongly with anti- β 2-glycoprotein-I than with antiphospholipid antibodies. Journal of Rheumatology 1995 22 10 1899 1906 2-s2.0-0028866838
44. Bastos C. J., Queiroz A. C., Martinelli R., Cardiac involvement in systemic lupus erythematosus: anatomo-pathological study. Revista da Associação Médica Brasileira 1993 39 3 161 164 2-s2.0-17144461727
45. Chahade W. H., Sato E. I., Moura J. E. Jr., Costallat L. T. L., Andrade L. E. C., Occasional series: lupus around the world. Systemic lupus erythematosus in Sao Paulo, Brazil: a clinical and laboratory overview. Lupus 1995 4 2 100 103 2-s2.0-0029285583
46. Alves L. J., Hydalgo L., Rolim L. F., Campagnone G. Z., Aidar M. T., Novaes G. S., Kalil G., Clinical and laboratorial diagnosis of heart disease in systemic lupus erythematosus. Arquivos Brasileiros de Cardiologia 1997 68 2 79 83 2-s2.0-2442424451 (Pubitemid 127512830)
47. Borba E. F., Bonfá E., Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997 6 6 533 539 2-s2.0-0030758970 (Pubitemid 27371222)
48. Costallat L. T. L., Lia C. P. L. C., Neto N. L., Yamada R. M., Samara A. M., Causes of death in systemic lupus erythematosus. Revista Brasileira de Reumatologia 1997 37 4 205 209 2-s2.0-0030778424 (Pubitemid 27501916)
49. Rocha M. C. B. T., Teixeira S. S., Bueno C., Vendramini M. B. G., Martinelli R. P., Santiago M. B., Demographic, clinical, and laboratory profile of 100 patients with systemic lupus erythematosus in the State of Bahia. Revista Brasileira de Reumatologia 2000 40 5 221 230 2-s2.0-0033635951
50. Travassos A. C., Rocha M. C., Souza S., Brandao C., Silva J. F., Santiago M., Freqtiencia dos anticorpos antifosfolfpides (aFL) em portadores de lupus eritematoso sistemico (LES) no Estado da Bahia. Revista Brasileira de Reumatologia 2000 40 183 188
51. Falcão C. A., Alves I. C., Chahade W. H., Duarte A. L. B. P., Lucena-Silva N., Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arquivos Brasileiros de Cardiologia 2002 79 3 285 291 2-s2.0-0036726452
52. Sella E. M. C., Sato E. I., Barbieri A., Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy. Arthritis and Rheumatism 2003 48 11 3168 3175 2-s2.0-0242411865 10.1002/art.11260 (Pubitemid 37409328)
53. Sella E. M. C., Sato E. I., Leite W. A., Filho J. A. O., Barbieri A., Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Annals of the Rheumatic Diseases 2003 62 11 1066 1070 2-s2.0-0142187605 10.1136/ard.62.11.1066 (Pubitemid 37323570)
54. Soares M., Reis L., Papi J. A. S., Cardoso C. R. L., Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients. Lupus 2003 12 10 788 794 2-s2.0-0142023730 10.1191/0961203303lu447xx (Pubitemid 37295816)
55. Cardoso C. R. L., Sales M. A. O., Papi J. A. S., Salles G. F., QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 2005 14 10 846 852 2-s2.0-27744593641 10.1191/0961203305lu2225oa (Pubitemid 41597622)
56. da Rocha M. C. B.T., Vilar M. J. P., Freire E. A. M., Santiago M. B., Arterial occlusion in systemic lupus erythematosus: a good prognostic sign? Clinical Rheumatology 2005 24 6 602 605 2-s2.0-27844606365 10.1007/s10067-005- 1111-z (Pubitemid 41644329)
57. Shinzato M. M., Bueno C., Viana V. S. T., Borba E. F., Gonçalves C. R., Bonfá E., Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis. Lupus 2005 14 12 953 958 2-s2.0-30644474164 10.1191/0961203305lu2252oa (Pubitemid 43088269)
58. de Souza A. W. S., Hatta F. S., Miranda F. Jr., Sato E. I., Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. Sao Paulo Medical Journal 2005 123 3 137 142 2-s2.0-22244469455 (Pubitemid 40990717)
59. Freire B. F. A., da Silva R. C., Fabro A. T., dos Santos D. C., Is systemic lupus erithematosus a new risk factor for atherosclerosis? Arquivos brasileiros de cardiologia 2006 87 3 300 306 2-s2.0-39049191776
60. Telles R. W., Lanna C. C. D., Ferreira G. A., de Carvalho M. A. P., Ribeiro A., Freqüência de doença cardiovascular aterosclerótica e de seus fatores de risco em pacientes com lúpus eritematoso sistêmico. Revista Brasileira de Reumatologia 2007 47 165 173
61. Cardoso C. R. L., Signorelli F. V., Papi J. A. S., Salles G. F., Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study. Lupus 2008 17 11 1042 1048 2-s2.0-61549123278 10.1177/0961203308093829
62. Cardoso C. R. L., Signorelli F. V., Papi J. A., Salles G. F., Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. Rheumatology International 2008 28 4 323 327 2-s2.0-38049091101 10.1007/s00296-007-0447-x
63. Telles R. W., Lanna C. C. D., Ferreira G. A., Souza A. J., Navarro T. P., Ribeiro A. L., Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. Lupus 2008 17 2 105 113 2-s2.0-40449121144 10.1177/0961203307085312 (Pubitemid 351350573)
64. Cadaval R. A. M., Martinez J. E., Mazzolin M. A., Barros R. G. T., de Almeida F. A., Avaliação do risco coronariano em mulheres com lúpus eritematoso sistêmico. Revista Brasileira de Reumatologia 2009 49 6 10.1590/S0482-50042009000600003
65. dos Santos F. D. M. M., Borges M. C., Correia M. I. T. D., Telles R. W., Lanna C. C. D., Assessment of nutritional status and physical activity in systemic lupus erythematosus patients. Revista Brasileira de Reumatologia 2010 50 6 631 645 2-s2.0-79251525912
66. Ribeiro G. G., Bonfá E., Neto R. S., Abe J., Caparbo V. F., Borba E. F., Lopes J. B., Gebrim E., Pereira R. M. R., Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients. Lupus 2010 19 1 27 33 2-s2.0-74849126013 10.1177/0961203309345778
67. Shinjo S. K., Bonfá E., Wojdyla D., Borba E. F., Ramirez L. A., Scherbarth H. R., Tavares Brenol J. C., Chacón-Diaz R., Neira O. J., Berbotto G. A., de la Torre I. G., Acevedo-Vázquez E. M., Massardo L., Barile-Fabris L. A., Caeiro F., Silveira L. H., Sato E. I., Buliubasich S., Alarcón G. S., Pons-Estel B. A., Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis and Rheumatism 2010 62 3 855 862 2-s2.0-77649103505 10.1002/art.27300
68. Telles R. W., Lanna C. C. D., Ferreira G. A., Ribeiro A. L., Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics. Lupus 2010 19 7 803 809 2-s2.0-77952931596 10.1177/0961203309359781
69. Lozovoy M. A. B., Simão A. N. C., Hohmann M. S. N., Simão T. N. C., Barbosa D. S., Morimoto H. K., Reiche E. M. V., Cecchini R., Dichi I., Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus 2011 20 13 1356 1364 2-s2.0-81555203187 10.1177/0961203311411348
70. Souza D. C. C., Santo A. H., Sato E. I., Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis. Journal of Rheumatology 2012 39 3 496 503 2-s2.0-84857853152 10.3899/jrheum.110241
71. de Miranda Moura dos Santos F., Borges M. C., Telles R. W., Correia M. I. T. D., Lanna C. C. D., Excess weight and associated risk factors in patients with systemic lupus erythematosus. Rheumatology International 2013 33 681 688 2-s2.0-84859897290 10.1007/s00296-012-2402-8
72. Gobaira Maluf J., Zghaib Abad A., López P. A. R., The heart in systemic lupus erythematosus. Study in 32 non-selected patients (author's transl). Archivos del Instituto de Cardiologia de Mexico 1982 52 3 223 228 2-s2.0-0020134182
73. Badui E., Garcia-Rubi D., Robles E., Jimenez J., Juan L., Deleze M., Diaz A., Mintz G., Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985 36 7 431 441 2-s2.0-0021817501 (Pubitemid 15247819)
74. Ruiz-Arguelles G. J., Ruiz-Arguelles A., Alarcon-Segovia D., Drenkard C., Villa A., Cabiedes J., Presno-Bernal M., Deleze M., Ortiz-Lopez R., Vazquez-Prado J., Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome. Journal of Rheumatology 1991 18 4 552 558 2-s2.0-0025729196
75. Salazar-Paramo M., de la Torre I. G., Fritzler M. J., Loyau S., Anglés-Cano E., Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis. Lupus 1996 5 4 275 278 2-s2.0-9544247771 (Pubitemid 26306235)
76. Zonana-Nacach A., Camargo-Coronel A., Yáñez P., de Lourdes Sánchez M., Jímenez-Balderas F. J., Aceves-Avila J., Martínez-Osuna P., Fuentes J., Medina F., Fraga A., Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998 7 2 119 123 2-s2.0-6844259880 10.1191/ 096120398678919831 (Pubitemid 28107977)
77. Gómez-Pacheco L., Villa A. R., Drenkard C., Cabiedes J., Cabral A. R., Alarcón-Segovia D., Serum anti- β 2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients. The American Journal of Medicine 1999 106 4 417 423 2-s2.0-0033113371 10.1016/S0002-9343(99)00053-4 (Pubitemid 29190594)
78. Salcido-Ochoa F., Cabiedes J., Alarcón-Segovia D., Cabral A. R., Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Journal of Clinical Rheumatology 2002 8 5 251 255 2-s2.0-0036792287
79. Juárez-Rojas J. G., Medina-Urrutia A. X., Posadas-Sánchez R., Jorge-Galarza E., Mendoza-Pérez E., Caracas-Portilla N., Cardoso-Saldaña G., Muñoz-Gallegos G., Posadas-Romero C., High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus. Lupus 2008 17 11 981 987 2-s2.0-61549139332 10.1177/0961203308093072
80. Romero-Díaz J., García-Sosa I., Sánchez-Guerrero J., Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. Journal of Rheumatology 2009 36 1 68 75 2-s2.0-58149502452 10.3899/jrheum.071244
81. Zonana-Nacach A., Santana-Sahagún E., Jiménez-Balderas F. J., Camargo-Coronel A., Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. Journal of Clinical Rheumatology 2008 14 2 74 77 2-s2.0-42049110219 10.1097/RHU.0b013e31816b2faa (Pubitemid 351519191)
82. Uribe A. G., Romero-Díaz J., Apte M., Fernández M., Burgos P. I., Reveille J. D., Sánchez-Guerrero J., Alarcón G. S., Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico. Rheumatology 2009 48 11 1392 1397 2-s2.0-73349093416
83. Alexánderson E., Ochoa J. M., Calleja R., Juárez-Rojas J. G., Prior J. O., Jácome R., Romero E., Meave A., Posadas-Romero C., Endothelial dysfunction in systemic lupus erythematosus: evaluation with 13N-ammonia PET. Journal of Nuclear Medicine 2010 51 12 1927 1931 10.2967/jnumed.110.078212
84. Romero-Díaz J., Vargas-Vóracková F., Kimura-Hayama E., Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology 2012 51 1 110 119 10.1093/rheumatology/ker307
85. Toloza S. M. A., Roseman J. M., Alarcón G. S., McGwin G. Jr., Uribe A. G., Fessler B. J., Bastian H. M., Vilá L. M., Reveille J. D., Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis and Rheumatism 2004 50 10 3177 3186 2-s2.0-5644256975 10.1002/art.20578 (Pubitemid 39371994)
86. Szalai A. J., Alarcón G. S., Calvo-Alén J., Toloza S. M. A., McCrory M. A., Edberg J. C., McGwin G. Jr., Bastian H. M., Fessler B. J., Vilá L. M., Kimberly R. P., Reveille J. D., Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology 2005 44 7 864 868 2-s2.0-22844435417 10.1093/rheumatology/keh613 (Pubitemid 41511179)
87. Kaiser R., Li Y., Chang M., Catanese J., Begovich A. B., Brown E. E., Edberg J. C., McGwin G. Jr., Alarcn G. S., Ramsey-Goldman R., Reveille J. D., Vilá L. M., Petri M. A., Kimberly R. P., Taylor K. E., Criswell L. A., Genetic risk factors for thrombosis in systemic lupus erythematosus. Journal of Rheumatology 2012 39 8 1603 1610 10.3899/jrheum.111451
88. Finkielman S., Bleichmar N. M., Norymberg M., Agrest A., Arterial hypertension in systemic lupus erythematosus. Medicina 1969 29 3 165 170 2-s2.0-0014516524
89. Bellomio V., Spindler A., Lucero E., Berman A., Santana M., Moreno C., Pardo Hidalgo R., Paira S., Graf C., Cocco J. A. M., Citera G., Arriola M. S., Gómez G., Barreira J. C., Messina O., Asnal C., Carrillo D., Gervilla A., García L., Máscolo M., de la Sota M., Rosso G., Somma L. F., Fernández Sosa R., Rillo O., Caracciolo J. A., Lancioni G., Gómez A., Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 2000 9 5 377 381 2-s2.0-0034046233 (Pubitemid 30389042)
90. Zonana-Nacach A., Santana-Sahagún E., Jiménez-Balderas F. J., Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus 2009 18 11 1019 1025 10.1177/0961203309105876
91. Vilá L. M., Mayor A. M., Valentín A. H., García-Soberal M., Vilá S., Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999 8 4 279 286 2-s2.0-0033041506 10.1191/096120399678847803 (Pubitemid 29292092)
92. Rodriguez V. E., Gonzalez-Pares E. N., Rivera C., Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Puerto Rico Health Sciences Journal 2006 25 4 307 313 2-s2.0-34548407051
93. Fernández M., Calvo-Alén J., Bertoli A. M., Bastian H. M., Fessler B. J., McGwin G. Jr., Reveille J. D., Vilá L. M., Alarcón G. S., Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. Journal of Clinical Rheumatology 2007 13 5 261 265 2-s2.0-35148869629 10.1097/RHU.0b013e318156bbf5 (Pubitemid 47549163)
94. Negrón A. M., Molina M. J., Mayor A. M., Rodríguez V. E., Vilá L. M., Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus 2008 17 4 348 354 2-s2.0-43249117177 10.1177/0961203307086645 (Pubitemid 351655804)
95. Yassin L. M., Londoño J., Montoya G., de Sanctis J. B., Rojas M., Ramírez L. A., García L. F., Vásquez G., Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL. Autoimmunity 2011 44 3 201 210 2-s2.0-79953125414 10.3109/08916934.2010.530626
96. Abumohor P., Cerda C., Neira O., Palma S., Alvarado M. A., Basualdo J., Bravo M., Guzmán L., Anticardiolipin antibodies in systemic lupus erythematosus: prevalence and clinical associations. Revista Medica de Chile 1991 119 5 517 523 2-s2.0-0026158556
97. Alarcón-Segovia D., Alarcón-Riquelme M. E., Cardiel M. H., Caeiro F., Massardo L., Villa A. R., Pons-Estel B. A., Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis and Rheumatism 2005 52 4 1138 1147 2-s2.0-17244373451 10.1002/art.20999 (Pubitemid 40530121)
98. Manzi S., Meilahn E. N., Rairie J. E., Conte C. G., Medsger T. A. Jr., Jansen-McWilliams L., D'Agostino R. B., Kuller L. H., Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. The American Journal of Epidemiology 1997 145 5 408 415 2-s2.0-0031052874 (Pubitemid 27084212)
99. Kiani A. N., Magder L., Petri M., Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity. Journal of Rheumatology 2008 35 7 1300 1306 2-s2.0-47349107461 (Pubitemid 352000774)
100. Fischer L. M., Schlienger R. G., Matter C., Jick H., Meier C. R., Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. The American Journal of Cardiology 2004 93 2 198 200 2-s2.0-0346333033 10.1016/j.amjcard.2003.09.037 (Pubitemid 38058729)
101. Doria A., Iaccarino L., Ghirardello A., Zampieri S., Arienti S., Sarzi-Puttini P., Atzeni F., Piccoli A., Todesco S., Long-term prognosis and causes of death in systemic lupus erythematosus. The American Journal of Medicine 2006 119 8 700 706 2-s2.0-33746406072 10.1016/j.amjmed.2005.11.034 (Pubitemid 44128446)
102. Thompson T., Sutton-Tyrrell K., Wildman R. P., Kao A., Fitzgerald S. G., Shook B., Tracy R. P., Kuller L. H., Brockwell S., Manzi S., Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis and Rheumatism 2008 58 3 835 842 2-s2.0-40549125604 10.1002/art.23196 (Pubitemid 351364882)
103. Petri M., Perez-Gutthann S., Spence D., Hochberg M. C., Risk factors for coronary artery disease in patients with systemic lupus erythematosus. The American Journal of Medicine 1992 93 5 513 519 2-s2.0-0026459695 10.1016/0002-9343(92)90578-Y
104. Urowitzx M. B., Ibañez D., Gladman D. D., Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. Journal of Rheumatology 2007 34 1 70 75 2-s2.0-33846260276 (Pubitemid 46106565)
105. Urowitz M. B., Gladman D., Ibañez D., Bae S. C., Sanchez-Guerrero J., Gordon C., Clarke A., Bernatsky S., Fortin P. R., Hanly J. G., Wallace D. J., Isenberg D., Rahman A., Alarcón G. S., Merrill J. T., Ginzler E., Khamashta M., Nived O., Sturfelt G., Bruce I. N., Steinsson K., Manzi S., Ramsey-Goldman R., Dooley M. A., Zoma A., Kalunian K., Ramos M., Van Vollenhoven R. F., Aranow C., Stoll T., Petri M., Maddison P., Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care and Research 2010 62 6 881 887 2-s2.0-77953084931 10.1002/acr.20122
106. Symmons D. P. M., Gabriel S. E., Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nature Reviews Rheumatology 2011 7 7 399 408 2-s2.0-79960015053 10.1038/nrrheum.2011.75
107. Scalzi L. V., Bhatt S., Gilkeson R. C., Shaffer M. L., The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus 2009 18 14 1289 1297 2-s2.0-74049125350
108. Urowitz M. B., Gladman D., Ibañez D., Fortin P., Sanchez-Guerrero J., Bae S., Clarke A., Bernatsky S., Gordon C., Hanly J., Wallace D., Isenberg D., Ginzler E., Merrill J., Alarcon G., Steinsson K., Petri M., Dooley M. A., Bruce I., Manzi S., Khamashta M., Ramsey-Goldman R., Zoma A., Sturfelt G., Nived O., Maddison P., Font J., Van Vollenhoven R., Aranow C., Kalunian K., Stoll T., Buyon J., Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 2007 16 9 731 735 2-s2.0-34948827357 10.1177/0961203307081113 (Pubitemid 47517869)
109. Gustafsson J., Gunnarsson I., Börjesson O., Pettersson S., Möller S., Fei G. Z., Elvin K., Simard J. F., Hansson L. O., Lundberg I. E., Larsson A., Svenungsson E., Predictors of the first cardiovascular event in patients with systemic lupus erythematosus-a prospective cohort study. Arthritis Research and Therapy 2009 11 6, article R186 10.1186/ar2878
110. Gustafsson J. T., Simard J. F., Gunnarsson I., Elvin K., Lundberg I. E., Hansson L. O., Larsson A., Svenungsson E., Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Research and Therapy 2012 14 article R46 2-s2.0-84857676725 10.1186/ar3759
111. Bertoli A. M., Vilá L. M., Alarcón G. S., McGwin G. Jr., Edberg J. C., Petri M., Ramsey-Goldman R., Reveille J. D., Kimberly R. P., Factors associated with arterial vascular events in PROFILE: a multiethnic lupus cohort. Lupus 2009 18 11 958 965 2-s2.0-70349478695 10.1177/0961203309104862
112. Driessen M. T., Koppes L. L. J., Veldhuis L., Samoocha D., Twisk J. W. R., Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam growth and health longitudinal study. European Journal of Clinical Nutrition 2009 63 4 536 542 2-s2.0-64249111578 10.1038/ejcn.2008.6
113. Uiterwaal C. S. P. M., Verschuren W. M. M., Bueno-de-Mesquita H. B., Ocké M., Geleijnse J. M., Boshuizen H. C., Peeters P. H. M., Feskens E. J. M., Grobbee D. E., Coffee intake and incidence of hypertension. The American Journal of Clinical Nutrition 2007 85 3 718 723 2-s2.0-33847787437 (Pubitemid 46393502)
114. Zhang Z., Hu G., Caballero B., Appel L., Chen L., Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. The American Journal of Clinical Nutrition 2011 93 6 1212 1219 2-s2.0-79956298128 10.3945/ajcn.110.004044
115. Klag M. J., Wang N. Y., Meoni L. A., Brancati F. L., Cooper L. A., Liang K. Y., Young J. H., Ford D. E., Coffee intake and risk of hypertension: the
116. Di Castelnuovo A., Di Giuseppe R., Iacoviello L., de Gaetano G., Consumption of cocoa, tea and coffee and risk of cardiovascular disease. European Journal of Internal Medicine 2012 23 1 15 25 2-s2.0-83555174805 10.1016/j.ejim.2011.07.014
117. Jee S. H., He J., Whelton P. K., Suh I., Klag M. J., The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999 33 2 647 652 2-s2.0-0344267654 (Pubitemid 29091641)
118. Nardini M., Natella F., Scaccini C., Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets 2007 18 3 224 243 2-s2.0-34248374115 10.1080/09537100601078083 (Pubitemid 46744120)
119. Shechter M., Shalmon G., Scheinowitz M., Koren-Morag N., Feinberg M. S., Harats D., Sela B. A., Sharabi Y., Chouraqui P., Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. The American Journal of Cardiology 2011 107 9 1255 1261 2-s2.0-79954588047 10.1016/j.amjcard.2010.12.035
120. Svenungsson E., Jensen-Urstad K., Heimbürger M., Silveira A., Hamsten A., de Faire U., Witztum J. L., Frostegård J., Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001 104 16 1887 1893 2-s2.0-0035899949 (Pubitemid 32983229)
121. Roman M. J., Salmon J. E., Sobel R., Lockshin M. D., Sammaritano L., Schwartz J. E., Devereux R. B., Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. The American Journal of Cardiology 2001 87 5 663 666 2-s2.0-0035282653 10.1016/S0002-9149(00)01453-3 (Pubitemid 32178473)
122. López-Jaramillo P., Velandia-Carrillo C., Alvarez-Camacho J., Cohen D. D., Sánchez-Solano T., Castillo-López G., Inflammation and hypertension: are there regional differences? International Journal of Hypertension 2013 2013 12 492094 10.1155/2013/492094
123. McMahon M., Grossman J., Skaggs B., FitzGerald J., Sahakian L., Ragavendra N., Charles-Schoeman C., Watson K., Weng K. W., Volkmann E., Chen W., Gorn A., Karpouzas G., Weisman M., Wallace D. J., Hahn B. H., Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis and Rheumatism 2009 60 8 2428 2437 2-s2.0-68049098209 10.1002/art.24677
124. McMahon M., Skaggs B. J., Sahakian L., Grossman J., FitzGerald J., Ragavendra N., Charles-Schoeman C., Chernishof M., Gorn A., Witztum J. L., Wong W. K., Weisman M., Wallace D. J., La Cava A., Hahn B. H., High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Annals of the Rheumatic Diseases 2011 70 9 1619 1624 2-s2.0-80051471532 10.1136/ard.2010.142737
125. Touma Z., Gladman D. D., Ibañez D., Urowitz M. B., Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. Rheumatology 2012 51 3 528 534 2-s2.0-84857536180 10.1093/rheumatology/ker339 ker339
126. Mikdashi J., Handwerger B., Langenberg P., Miller M., Kittner S., Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 2007 38 2 281 285 2-s2.0-33846621547 10.1161/01.STR.0000254476.05620.14 (Pubitemid 46184295)
127. Nikpour M., Urowitz M. B., Ibanez D., Harvey P. J., Gladman D. D., Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Research and Therapy 2011 13 article R156 2-s2.0-80053173790 10.1186/ar3473
128. Westerweel P. E., Luyten R. K. M. A. C., Koomans H. A., Derksen R. H. W. M., Verhaar M. C., Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis and Rheumatism 2007 56 5 1384 1396 2-s2.0-34248585897 10.1002/art.22568 (Pubitemid 46764065)
129. Frostegård J., Atherosclerosis in patients with autoimmune disorders. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 9 1776 1785 2-s2.0-24144438580 10.1161/01.ATV.0000174800.78362.ec (Pubitemid 41243443)
130. Rhew E. Y., Ramsey-Goldman R., Premature atherosclerotic disease in systemic lupus erythematosus-role of inflammatory mechanisms. Autoimmunity Reviews 2006 5 2 101 105 2-s2.0-31144476123 10.1016/j.autrev.2005.08.008 (Pubitemid 43129536)
131. Sherer Y., Shoenfeld Y., Mechanisms of disease: atherosclerosis in autoimmune diseases. Nature Clinical Practice Rheumatology 2006 2 2 99 106 2-s2.0-32644437182 10.1038/ncprheum0092 (Pubitemid 43239209)
132. McMahon M., Hahn B. H., Skaggs B. J., Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Review of Clinical Immunology 2011 7 2 227 241 2-s2.0-79953118552 10.1586/eci.10.98
133. Nikpour M., Urowitz M. B., Gladman D. D., Premature atherosclerosis in systemic lupus erythematosus. Rheumatic Disease Clinics of North America 2005 31 2 329 354 2-s2.0-19544382185 10.1016/j.rdc.2005.01.001 (Pubitemid 40732492)
134. Full L. E., Ruisanchez C., Monaco C., The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research and Therapy 2009 11 2, article 217 2-s2.0-67650120701
135. Sarmiento-Monroy J. C., Amaya-Amaya J., Espinosa-Serna J. S., Herrera-Díaz C., Anaya J. M., Rojas-Villarraga A., Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. Arthritis 2012 2012 17 371909 10.1155/2012/371909
136. Amaya-Amaya J., Sarmiento-Monroy J. C., Mantilla R. D., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J. M., Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunologic Research 2013 56 2-3 267 286 10.1007/s12026-013-8398-7
137. Troelsen L. N., Garred P., Christiansen B., Torp-Pedersen C., Jacobsen S., Genetically determined serum levels of mannose-binding lectin correlate negatively with common carotid intima-media thickness in systemic lupus erythematosus. Journal of Rheumatology 2010 37 9 1815 1821 2-s2.0-77956483576 10.3899/jrheum.100158
138. Marasini B., Massarotti M., de Monti M., Erario M., Ghilardi G., Biondi M. L., Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus. Journal of Clinical Immunology 2008 28 2 131 133 2-s2.0-40149084552 10.1007/s10875-007-9146-3
139. Kahlenberg J. M., Kaplan M. J., Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annual Review of Medicine 2013 64 249 263 10.1146/annurev-med-060911-090007
140. Kawai V. K., Solus J. F., Oeser A., Rho Y. H., Raggi P., Bian A., Gebretsadik T., Shintani A., Stein C. M., Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Lupus 2011 20 14 1526 1534 2-s2.0-82955222903 10.1177/0961203311420317
141. Wilson P. W. F., Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. The American Journal of Medicine 2008 121 10 S15 S20 2-s2.0-52949098281 10.1016/j.amjmed.2008.06.012
142. Ridker P. M., Buring J. E., Rifai N., Cook N. R., Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. The Journal of the American Medical Association 2007 297 6 611 619 2-s2.0-33846996345 10.1001/jama.297.6.611
143. Peters M. J. L., Symmons D. P. M., McCarey D., Dijkmans B. A. C., Nicola P., Kvien T. K., McInnes I. B., Haentzschel H., Gonzalez-Gay M. A., Provan S., Semb A., Sidiropoulos P., Kitas G., Smulders Y. M., Soubrier M., Szekanecz Z., Sattar N., Nurmohamed M. T., EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 2010 69 2 325 331 2-s2.0-75749118959 10.1136/ard.2009.113696
144. Petri M., Magder L., SLE cardiovascular risk equation. Lupus 2013 22 1 3 5 10.1177/0961203312462266
145. Elliott J. R., Manzi S., Edmundowicz D., The role of preventive cardiology in systemic lupus erythematosus. Current Rheumatology Reports 2007 9 2 125 130 2-s2.0-34250665907 10.1007/s11926-007-0006-1 (Pubitemid 46932718)
146. Bruce I. N., Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin? Best Practice and Research: Clinical Rheumatology 2005 19 5 823 838 2-s2.0-24344499558 10.1016/j.berh.2005. 05.001 (Pubitemid 41258585)
147. Elliott J. R., Manzi S., Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Best Practice and Research: Clinical Rheumatology 2009 23 4 481 494 2-s2.0-67649814984 10.1016/j.berh.2009.03.005
148. Petri M. A., Kiani A. N., Post W., Christopher-Stine L., Magder L. S., Lupus Atherosclerosis Prevention Study (LAPS). Annals of the Rheumatic Diseases 2011 70 5 760 765 2-s2.0-79953324124 10.1136/ard.2010.136762
149. Ben-Zvi I., Kivity S., Langevitz P., Shoenfeld Y., Hydroxychloroquine: from malaria to autoimmunity. Clinical Reviews in Allergy and Immunology 2012 42 2 145 153 2-s2.0-78650952708 10.1007/s12016-010-8243-x
150. Katz S. J., Russell A. S., Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action. Current Opinion in Rheumatology 2011 23 3 278 281 2-s2.0-79955017501 10.1097/BOR.0b013e32834456bf
151. Morris S. J., Wasko M. C. M., Antohe J. L., Sartorius J. A., Kirchner H. L., Dancea S., Bili A., Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care and Research 2011 63 4 530 534 2-s2.0-79957526236
152. Penn S. K., Kao A. H., Schott L. L., Elliott J. R., Toledo F. G. S., Kuller L., Manzi S., Wasko M. C. M., Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. Journal of Rheumatology 2010 37 6 1136 1142 2-s2.0-77953214748 10.3899/jrheum.090994
153. Rekedal L. R., Massarotti E., Garg R., Bhatia R., Gleeson T., Lu B., Solomon D. H., Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases. Arthritis and Rheumatism 2010 62 12 3569 3573 2-s2.0-78650050052 10.1002/art.27703
154. Kaiser R., Cleveland C. M., Criswell L. A., Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Annals of the Rheumatic Diseases 2009 68 2 238 241 2-s2.0-58849159669 10.1136/ard.2008.093013
155. Jung H., Bobba R., Su J., Shariati-Sarabi Z., Gladman D. D., Urowitz M., Lou W., Fortin P. R., The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis and Rheumatism 2010 62 3 863 868 2-s2.0-77649142208 10.1002/art.27289
156. Petri M., Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Current Rheumatology Reports 2011 13 1 77 80 2-s2.0-79551544891 10.1007/s11926-010-0141- y
157. Alarcón G. S., McGwin G., Bertoli A. M., Fessler B. J., Calvo-Alén J., Bastian H. M., Vilà L. M., Reveille J. D., Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Annals of the Rheumatic Diseases 2007 66 9 1168 1172 2-s2.0-34548190213 10.1136/ard.2006.068676 (Pubitemid 47309732)
158. Perricone C., Agmon-Levin N., Colafrancesco S., Shoenfeld Y., Vitamins and systemic lupus erythematosus: to D or not to D. Expert Review of Clinical Immunology 2013 9 5 397 399 10.1586/eci.13.23
159. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Brey R., Cervera R., Doria A., Jayne D., Khamashta M. A., Kuhn A., Gordon C., Petri M., Rekvig O. P., Schneider M., Sherer Y., Shoenfeld Y., Smolen J. S., Talarico R., Tincani A., van Vollenhoven R. F., Ward M. M., Werth V. P., Carmona L., European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Annals of the Rheumatic Diseases 2010 69 7 1269 1274 2-s2.0-77953956376 10.1136/ard.2009.117200